IMR Press / CEOG / Volume 31 / Issue 4 / pii/2004070

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Effect of the WHI study on the attitude of Israeli gynecologists to hormonal therapy during menopause

Show Less
1 Department of Obstetrics & Gynecology, Rabin Medical Center, Petach Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (Israel)
Clin. Exp. Obstet. Gynecol. 2004, 31(4), 267–268;
Published: 10 December 2004
Abstract

Objective: To evaluate the attitude of Israeli gynecologists to the use of hormonal therapy (HT) during menopause consequent to the recent publication of the Women’s Health Initiative (WHI) study. Design: Gynecologists present at the annual convention of the Israeli Society of Obstetrics and Gynecology in the community were asked to complete a 5-item questionnaire on their opinions regarding hormone therapy (HT) use in light of the WHI study. Results: Ninety-five percent of the physicians believed that HT is still a legitimate treatment modality during menopause, although almost 40% would now limit it to the management of climacteric symptoms. As a result of the WHI study, 65% of the physicians recommended cessation of HT use in up to 30% of their treated postmenopausa1 patients. The responders estimated that about 40% of their patients using HT ceased treatment on their own initiative following publication of the WHl study. Conclusions: Both physicians and patients were clearly influenced by the WHI study. Today, HT is being reserved by most gyne­cologists in Israel for the treatment of menopausal symptoms and is not being used as a preventive measure against future complications of heart disease and osteoporosis.

Keywords
HT
Menopause
WHI study
Share
Back to top